allergy-immunotherapy-market

Allergy Immunotherapy Market By Allergy (Food Allergy, Allergic Rhinitis, Skin Allergy, Insect-Bite Allergy, Other Allergies), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth, Future Prospects, And Competitive Landscape, 2024 - 2032

04 Apr 2019 Format PDF icon PPT icon XLS icon Request Sample

Industry Outlook

Allergy immunotherapy market accounted for a market value of US$ 1,953.1 Mn in 2020 and is projected to grow at a CAGR of 10.1% during the forecast period from 2023 to 2032. Allergy immunotherapy helps to prevent or minimize allergic reactions and provide long-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.

"Subcutaneous immunotherapy (SCIT) is highly demanded treatment for allergic rhinitis & asthma as it provides long-term relief to the patients"

SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of allergic reaction by focusing the basic mechanism of immunology. Thus, in 2020 SCIT identified as the largest allergy immunotherapy type that is preferred and adopted by most of the physicians. In addition to that, compared with conventional treatment the cost-effectiveness of SCIT is high and new molecules under trials will assist the overall growth of allergy immunotherapy.

"Air pollution has increased due to infrastructural development & industrialization in China & India specifically assisting the growth in asthma & allergic rhinitis"

The Asia Pacific is the fastest growing segment due to key driving factors such as rising prevalence & awareness related to allergic conditions, and industrialization & infrastructural development has increased air pollution in China & India. According to the World Health Organization (WHO), there has been significant growth in the prevalence of allergic rhinitis in Asia–Pacific within the last decade that has increased the economic burden. According to experts, the key factors responsible for sudden growth in allergic rhinitis is result of changing the environment, development in hygiene & reduced infections, and increasing cases of genetic complications.

This report also covers segments including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information against global allergy immunotherapy market. The key market players analyzed in the report based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Merck KGaA, ALK-Abello A/S, HAL Allergy Group, Circassia, Aimmune Therapeutics, Anergis, Biomay AG, Stallergenes Greer, DBV Technologies, Allergy Therapeutics, Hollister Stier, Leti, WOLW Pharma, Allergopharma, and Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Allergy Immunotherapy market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Allergy Immunotherapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Allergy
  • Food Allergy
  • Allergic Rhinitis
  • Skin Allergy
  • Insect-bite Allergy
  • Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)

Treatment
  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Allergy Immunotherapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Allergy Immunotherapy market?
  • Which is the largest regional market for Allergy Immunotherapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Allergy Immunotherapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Allergy Immunotherapy market worldwide?
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports